United States · 
Who invested in ExplORer Surgical?
ExplORer Surgical's investors include Aphelion Capital.
United States · Funded startup
Who invested in ExplORer Surgical
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2019, from 1 source
- Latest round
- Round, $5.0MApr 2019
- Investors
- 1
The rounds
- Apr 2019
Founders and team
From ExplORer Surgical's own website and the SEC filings it signed: 9 on the team.
- Tina Vatanka MurphyPresident & Chief Executive Officer
- Nedzad FajicPresident, GHX Europe
- Chris BatsonChief Financial Officer
- Chris LuomaChief Strategy Officer
- Chrystie LeonardChief Customer Experience Officer
- Liz RaffertyChief People Officer
- Steve JacksonChief Revenue Officer
- Eugene FineExecutive Officeri
- Jennifer FriedExecutive Officer, Directori
On the board, as filediDenis HarringtonImmanuel ThangarajKris JohnsonNed Scheetz
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists ExplORer Surgical as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ExplORer Surgical
How much has ExplORer Surgical raised?
ExplORer Surgical has raised $5.0M across 1 round since 2019.
When did ExplORer Surgical last raise?
ExplORer Surgical's most recent round was an Undisclosed round of $5.0M in Apr 2019.
What was ExplORer Surgical's biggest round?
Its most recent round, $5.0M in Apr 2019, is also its largest on record.
Who backed ExplORer Surgical first?
ExplORer Surgical's first round on record, in Apr 2019, was backed by Aphelion Capital.
What stage is ExplORer Surgical at?
ExplORer Surgical's latest named round is an Undisclosed round, in Apr 2019.
Where is ExplORer Surgical based?
ExplORer Surgical is based in the United States.
Companies like ExplORer Surgical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.